Will Moderna Be a Trillion-Dollar Stock by 2030?
Investing in a company on a meteoric trajectory is one of the fastest ways to grow your portfolio, and predicting how much a business will be worth in the future is a key tool to evaluate rising stars. With its rapidly produced and highly effective coronavirus vaccine, it's no surprise that Moderna (NASDAQ: MRNA) is one of the most-discussed stocks of the year. But could it be worth $1 trillion by the close of the decade if things continue to go as swimmingly as they did in 2020 and 2021?
With a few calculations and a handful of reasonable assumptions, we can chart a course to project what needs to happen for the company to hit that target. If you're feeling your eyes glaze over already, don't give up just yet -- the math is much easier than it seems.
Image source: Getty Images.
Source Fool.com
